CD70 expression in thymic carcinoma

American Journal of Surgical Pathology

Volumn 24, Issue 5, 2000, Pages 742-746

  Hishima, Tsunekazu ^a   Fukayama, Masashi ^b   Hayashi, Yukiko ^a   Fujii, Takeshi ^c   Ooba, Takayo ^a   Funata, Nobuaki ^a   Koike, Mono ^a  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

CD70; Epstein Barr virus; Thymic carcinoma

Indexed keywords

CD70 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; THYMUS CANCER; THYMUS DISEASE;

ANTIGENS, CD; ANTIGENS, CD70; BLOTTING, NORTHERN; CARCINOMA; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; NEOPLASMS, GLANDULAR AND EPITHELIAL; RNA, MESSENGER; THYMUS NEOPLASMS;

EID: 0034064586     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200005000-00014     Document Type: Article

References (24)

1. Agathanggelou A, Niedobitek G, Chen R, et al. Expression of immune regulatory molecules in Epstein-Barr virus-associated nasopharyngeal carcinomas with prominent lymphoid stroma: evidence for a functional interaction between epithelial tumor cells and infiltrating lymphoid cells. Am J Pathol 1995;147:1152-60.
2. Alsaati T, Mazerolles C, Caspar S, et al. Production of two mAb identifying a novel activation antigen (CD70w), using spleen cells from nude mice bearing HLY-1 cell line. In: Knap W, Dürken B, Gilks WR, et al., eds. Leucocyte Typing IV. Oxford: Oxford University Press, 1989:452-5.
3. Anagnostopoulos I, Herbst H, Niedobitek G, et al. Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization. Blood 1989;74:810-6.
4. Bowman MR, Crimmins MAV, Yetz-Aldape J, et al. The cloning of CD70 and its identification as the ligand for CD27. J Immunol 1994;152:1756-61.
5. Chan JKC, Tsang WYW, Seneviatne S, et al. The MIC2 antibody O13: practical application for the study of thymic epithelial tumors. Am J Pathol 1995;19:1115-23.
6. Dimery IW, Lee JS, Blick M, et al. Association of Epstein-Barr virus with lymphoepithlioma of the thymus. Cancer 1988;61: 2475-80.
7. Foss HD, Herbst H, Oelmann E, et al. Lymphotoxin, tumor necrosis factor and interleukin-6 gene transcripts are present in Hodgkin and Reed-Sternberg cells of most Hodgkin's disease cases. Br J Haemotol 1993;84:627-35.
8. Fujii T, Kawai T, Saito K, et al. EBER-1 expression in thymic carcinoma. Acta Pathol Jpn 1993;43:107-10.
9. Fukayama M, Hayashi Y, Iwasaki Y, et al. Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach. Lab Invest 1994;71:427-35.
10. Goodwin RG, Alderson MR, Smith CA, et al. Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell 1993; 73:447-56.
11. Gruss HJ, Dower SK. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphoma. Blood 1995;85:3378-404.
12. Hintzen RQ, Lens SMA, Koopman G, et al. CD70 represents the human ligand for CD27. Int Immunol 1994;6:477-80.
13. Hishima T, Fukayama M, Fujisawa M, et al. CD5 expression in thymic carcinoma. Am J Pathol 1994;145:268-75.
14. Kirchner T, Schalke B, Buchward J, et al. Well-differentiated thymic carcinoma. An organotypical low-grade carcinoma with relationship to cortical thymoma. Am J Surg Pathol 1992;16:1153-69.
15. Kuo TT, Chan JK. Thymic carcinoma arising thymoma is associated with alterations in immunohistochemical profiles. Am J Surg Pathol 1998;22:1474-81.
16. Leyvraz S, Henle W, Chahinian AP, et al. Association of Epstein-Barr virus with thymic carcinoma. N Engl J Med 1985;312: 1296-9.
17. Matsuno Y, Mukai K, Uhara H, et al. Detection of Epstein-Barr virus DNA in a Japanese case of lymphoepithelioma-like thymic carcinoma. Jpn J Cancer Res 1992;83:127-30.
18. Niedobitek G, Fahraeus R, Herbst H, et al. The Epstein-Barr virus encoded membrane protein (LMP1) induces phenotypic changes in epithelial cells. Virchows Arch [B] 1992;62:55-9.
19. Niedobitek G, Young LS, Sam CK, et al. Expression of Epstein-Barr virus genes and of lymphocyte activation molecules in undifferentiated nasopharyngeal carcinomas. Am J Pathol 1992;140: 879-87.
20. Sato Y, Watanabe S, Mukai K, et al. An immunohistochemical study of thymic epithelial tumors. II: lymphoid component. Am J Surg Pathol 1986;10:862-70.
21. Shimosato Y, Mukai K. Tumors of the thymus and related lesions. In: Rosai J, ed. Atlas of Tumor Pathology. Tumors of the Mediastinum. Washington, DC: Armed Forces Institute of Pathology, 1997:33-238.
22. Stein H, Schwarting R, Niedobitek G, et al. Cluster report: CDw70. In: Knap W, Dürken B, Gilks WR, et al., eds. Leucocyte Typing IV. Oxford: Oxford University Press, 1989:446-9.
23. Suster S, Moran CA. Primary thymic epithelial neoplasms showing combined features of thymoma and thymic carcinoma. A clinicopathologic study of 22 cases. Am J Surg Pathol 1996;20:1469-80.
24. Weiss LM, Movahed LA, Warnke RA, et al. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 1989;320:502-6.